• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Myocarditis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

Background The risk of adverse cardiovascular events in patients with acute myocarditis
(AM) and desmosomal gene variants (DGV) remains unknown. Objectives The purpose of …

Arrhythmogenic cardiomyopathy (ACM) is a primary disease of the myocardium,
predominantly caused by genetic defects in proteins of the cardiac intercalated disc …

Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by
prominent “non-ischemic” myocardial scarring predisposing to ventricular electrical …

Cardiomyopathies (CMPs) are myocardial diseases in which the heart muscle is structurally
and functionally abnormal in the absence of coronary artery disease, hypertension, valvular …

Cardiac magnetic resonance (CMR) has become an essential tool for the evaluation of
patients affected or at risk of developing cardiomyopathies (CMPs). In fact, CMR not only …

Over recent years, preclinical and clinical evidence has implicated myocardial inflammation
(M-Infl) in the pathophysiology and phenotypes of traditionally genetic cardiomyopathies. M …

The authors present a clinical report focused on the overlap between myocarditis and
genetic cardiomyopathies of the dilated and arrhythmogenic spectrum. Our cohort was …

Arrhythmogenic cardiomyopathy (ACM) is a genetically determined myocardial disease,
characterized by myocytes necrosis with fibrofatty substitution and ventricular arrhythmias …